Court issues mixed ruling in Merck Sharp & Dohme, Pfizer vaccine patent battle

Intellectual Property 2020-10-15 4:47 pm By Miklos Bolza | Sydney

Pharmaceutical rivals Merck Sharp & Dohme and Pfizer have both suffered a blow in their efforts to patent a better pneumococcal vaccine, with a judge upholding both infringement and invalidity claims in the long-running case over the blockbuster Prevnar 13 vaccine.